ORIGINAL ARTIGLESRandomised controlled trial of nasal nicotine spray in smoking cessation
References (22)
- et al.
Controlled trial of transdermal nicotine patch in tobacco withdrawal
Lancet
(1989) - et al.
A new age for snuff
Lancet
(1980) - et al.
Predictors of outcome in a General Practitioner intervention against smoking
Prevent Med
(1986) - et al.
A double-blind trial of a 16-h transdermal nicotine patch in smoking cessation
N Engl J Med
(1991) Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials
JAMA
(1991)Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance
- G. Sutherland, Mah Russell, J. Stapleton, C. Feyerabend, O. Ferno, Nasal nicotine spray: a rapid nicotine delivery...
- et al.
Nasal nicotine solution as an aid to cigarette withdrawal: a pilot clinical trial
Br J Addict
(1987) - et al.
Daily intake of nicotine during cigarette smoking
Clin Pharmacol Ther
(1984) - et al.
Enhancing the impact of groups: an evaluation of two group formats for smokers
Br J Clin Psychol
(1985)
Cited by (278)
Comparative efficacy and safety of pharmacological interventions for smoking cessation in healthy adults: A network meta-analysis
2021, Pharmacological ResearchCitation Excerpt :The stepwise process of the study selection has been presented through the PRISMA flow chart (Fig. 1). The vital study characteristics of each included study have been summarized in eTable 1 [26–122]. Risk of bias was assessed by assessing each of the seven domains of risk of bias for individual studies and represented in eTable 2.
Combination Therapies for Smoking Cessation: A Hierarchical Bayesian Meta-Analysis
2016, American Journal of Preventive MedicineCitation Excerpt :The database search yielded 14,998 records, with two records identified from other sources (Figure 1). After removing duplicates and screening titles and abstracts, 587 articles underwent full-text review, of which 123 met the predefined inclusion criteria (60,774 participants).13–135 These trials were conducted primarily in the general population (93 trials), and most trials recruited participants from North America, Europe, Australia/New Zealand, or some combination of these regions (117 trials).
How can we Improve on Modeling Nicotine Addiction to Develop Better Smoking Cessation Treatments?
2016, International Review of NeurobiologyOral side effects of locally delivered nicotine replacement therapy: A meta-analysis of randomized controlled trials
2023, International Journal of Dental Hygiene